Despite recent progress in women’s health issues, there are still many challenges women continue to face when accessing healthcare. Here, Alison Slingsby of HRA Pharma discusses the recent advancements made in the UK and where further development is required.
Women’s healthcare has long been a source of struggle for women across the world. Whether it is period poverty, birth control, pregnancy, menopause or conditions like endometriosis, women have had to fight to be listened to – and for access to appropriate care and products. Although many strides have been made over the past 50 years, there is still a long way to go.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
Contraception is a key area of women’s healthcare that can be extremely difficult to navigate. Finding the appropriate method can be a major challenge for people, with accessibility and cost also presenting issues. In recent years, companies have been working with the most common method of contraception, the pill, to make it more easily accessible to women, this includes the reclassification of contraceptive products from prescription only to over the counter (OTC).
This reclassification of contraceptive products is a major milestone for women. Last summer, a major breakthrough in the reclassification to OTC was made with the launch of the Hana pill. The launch took place following the authorisation for the reclassification of the desogestrel pill by the Medicines and Healthcare products Regulatory Agency (MHRA). This milestone meant that the progestogen-only pill, which contains 75mg of desogestrel, could be made available for women in the UK to buy without a prescription following a pharmacy consultation.1
Desogestrel has been used by millions of women for many years, it has a well-established safety profile2 and is supported by a number of British medical organisations.3 Launches such as this, which increase access to a contraceptive pill, will help to decrease the level of unplanned pregnancies which currently stands at 45 percent in England.4
The availability of contraception this way is an opportunity to revolutionise the industry for so many people in so many ways. This switch will help women who, as a result of emotional, lifestyle, career or accessibility reasons, do not have access to effective contraception through a General Practitioner (GP).
Changes such as this not only alter the industry but open up a much bigger conversation about the developments and research required in the wider women’s healthcare sector. In 2021, the conversation regarding another important women’s health issue came to the fore of public discourse. The topic of menopause was given a much-needed raise in profile when TV presenter Davina McCall and writer and activist Kate Muir filmed a documentary based on their menopause experience and that of women across the UK. The documentary was broadcast on Channel 4 and was a major turning point in enabling women to open up about their experiences and symptoms.
Two days after the documentary aired, The Menopause Charity was launched by doctors and patient activists to support women, encourage better access to hormone replacement therapy (HRT) and to help educate medical professionals. The first initiative by the charity was to offer a free six-hour online menopause course to every GP practice across the country.
With doctors and scientists passionate about the area… I am confident that there are many more important developments to come in the not-too-distant future”
In the months since the documentary many companies have made decisions to recognise menopause, providing extra support and leave to employees who need it. There are also developments being made in the area of menopause treatment, including new HRT formulations, alternative therapies, progesterone capsules and even laser vaginal rejuvenation. The medical world has celebrated this new open conversation around symptoms including night sweats, heavy bleeding, anxiety and low libido, and welcomed the development of workplace programmes to better support women at this time in their lives.5
Although many developments have been made, challenges within women’s healthcare remain. Some of the challenges identified by Dr Margaret Rose Cunningham, Chancellor’s Fellow and Lecturer in Cardiovascular Pharmacology at the University of Strathclyde, and an Academy of Medical Sciences (AMS) springboard awardee that recently featured in the #MedSciLife Campaign, include:
One in 10 women are affected by miscarriage and many will never know why
In a study of over 3000 women, two in five reported persistent incontinence up to twelve years after giving birth
One in five women in the UK will see five or more different midwives during the course of their pregnancy
Conditions such as endometriosis currently take an average of eight years to diagnose in the UK
A woman is 50 percent more likely to receive the wrong initial diagnosis for a heart attack
Women from the richest parts of England live an average of seven years longer than women from the poorest.6
Although we have a long way to go to ensure women across the world have equal access to appropriate medical care, the healthcare gap, as it is described by Peggy Maguire, Director General of the European Institute of Women’s Health, is becoming narrower thanks to the important progress made in the last two decades.7 With doctors and scientists passionate about the area and women being more educated about their bodies than ever, I am confident that there are many more important developments to come in the not-too-distant future.
Alison Slingsby is the International Marketing Manager, Women’s Health at HRA Pharma. She joined the French company in 2009 working in the UK office, initially launching ellaOne as a prescription-only medicine and then leading the team responsible for the implementation of non-prescription status in 2015. The activities resulted in ellaOne receiving several awards for the launch. Alison is now working in an international position supporting the further development of the brand.
About HRA
Created in 1996, the objective of HRA Pharma was to provide innovative solutions to medical needs that had not been addressed previously by large pharmaceutical groups. HRA Pharma is a leader within the market segments it operates in, after growing the brand with new products and expanding into new markets.
References
First progestogen-only contraceptive pills to be available to purchase from pharmacies [Internet]. GOV.UK. 2021 [cited 1 February 2022]. Available from: https://www.gov.uk/government/news/first…
Royal College of Obstetricians and Gynaecologists (RCOG). Better for women report [Internet]. London: Royal College of Obstetricians and Gynaecologists (RCOG); 2019 p. 13. Available from: https://www.rcog.org.uk/better-for-women
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.